D

DOD Biotech PCL
SET:DOD

Watchlist Manager
DOD Biotech PCL
SET:DOD
Watchlist
Price: 2.46 THB -1.6% Market Closed
Market Cap: 1.1B THB
Have any thoughts about
DOD Biotech PCL?
Write Note

Net Margin
DOD Biotech PCL

-21.4%
Current
-23%
Average
3.7%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
-21.4%
=
Net Income
-151.6m
/
Revenue
710.3m

Net Margin Across Competitors

Country TH
Market Cap 1.1B THB
Net Margin
-21%
Country FR
Market Cap 184.1B EUR
Net Margin
15%
Country UK
Market Cap 118.3B GBP
Net Margin
11%
Country IN
Market Cap 5.9T INR
Net Margin
17%
Country UK
Market Cap 34B GBP
Net Margin
10%
Country DE
Market Cap 27.9B EUR
Net Margin
8%
Country US
Market Cap 24.7B USD
Net Margin
3%
Country JP
Market Cap 3.1T JPY
Net Margin
4%
Country IN
Market Cap 1.3T INR
Net Margin
-3%
Country MY
Market Cap 66.7B MYR
Net Margin
-21%
Country IN
Market Cap 956.9B INR
Net Margin
15%

Profitability Report

View the profitability report to see the full profitability analysis for DOD Biotech PCL.

See Also

Discover More
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
-21.4%
=
Net Income
-151.6m
/
Revenue
710.3m
What is the Net Margin of DOD Biotech PCL?

Based on DOD Biotech PCL's most recent financial statements, the company has Net Margin of -21.4%.